Re: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits
posted on
Jul 08, 2019 09:29AM
It does seem as though they are dragging it out......maybe they want to include more MACE events in the trial outcome.......or maybe they don’t want to announce in the summer months. Who knows? There could be another AGM scheduled for September....that may be something. Lots of questions for sure, but as long as the outcome is positive that is the main thing.